v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
[1]
Assets    
Cash and cash equivalents $ 37,586 $ 37,953
Restricted cash 16,793 14,888
Mortgage loan receivables held for investment, net, at amortized cost:    
Mortgage loans receivable 2,790,138 2,217,375
Allowance for credit losses (47,095) (47,137)
Mortgage loan receivables held for sale 27,205 27,986
Securities 1,872,439 2,088,285
Real estate and related lease intangibles, net 776,496 703,537
Investments in and advances to unconsolidated ventures 41,494 44,468
Derivative instruments 116 264
Accrued interest receivable 16,997 15,890
Other assets 74,113 49,041
Total assets 5,606,282 5,152,550
Liabilities    
Debt obligations, net 4,004,904 3,510,402
Dividends payable 31,057 31,819
Accrued expenses 64,359 76,448
Other liabilities 79,246 52,524
Total liabilities 4,179,566 3,671,193
Commitments and contingencies (refer to Note 16) 0 0
Equity    
Additional paid-in capital 1,776,165 1,787,074
Treasury stock, 3,925,288 and 3,557,032 shares, at cost (40,933) (39,056)
Retained earnings (dividends in excess of earnings) (301,417) (260,084)
Accumulated other comprehensive income (loss) (4,613) (4,135)
Total shareholders’ equity 1,429,329 1,483,926
Noncontrolling interests in consolidated ventures (2,613) (2,569)
Total equity 1,426,716 1,481,357
Total liabilities and equity 5,606,282 5,152,550
Class A Common Stock    
Equity    
Class A common stock, par value $0.001 per share, 600,000,000 shares authorized; 130,790,591 and 130,790,591 shares issued and 126,865,303 and 127,233,559 shares outstanding as of June 30, 2026 and December 31, 2025, respectively. $ 127 $ 127
[1] Includes amounts relating to consolidated variable interest entities. Refer to Note 2 and Note 6.